RespireRx Pharmaceuticals Inc (RSPI): Myostrain, Here are some of Neuro's com...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	87
Posts	33471
Boards Moderated	87
Alias Born	03/22/2005

gfp927z

Re: myostrain post# 18053

Sunday, 06/15/2008 10:22:54 PM

Sunday, June 15, 2008 10:22:54 PM

Myostrain, Here are some of Neuro's comments from a while back concerning Greer's likely RD related milestones / royalties -

>>> Greer discovered that AMPA modulators could impact RD via the Pre-Botzinger complex, and thus patented the use of AMPA modulation for that purpose. Cortex owns CX717, but would not be able to market it for the RD use without a license from U.Alberta. They now have both the molecule, and an exclusive license for the RD use. I recall a small upfront payment ($250K?), I'm sure there will be milestones and small (typically 2-3%) royalties.

NeuroInvestment <<<

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent RSPI News

Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 12:45:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 12:30:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM